Skip to main content

Table 11 Non-parametric analysis of covariance of factors associated with CSF IGFBP1

From: Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals

CSF characteristics

Median (IQR)

P value

Neurocognitive impairment

  

0.613

 

Yes

0.49 (0.37 to 0.75)

 
 

No

0.47 (0.33 to 1.62)

 

AIDS

  

0.016

 

Yes

0.49 (0.36 to 1.17)

 
 

No

0.44 (0.34 to 0.65)

 

Body mass index (BMI)

  

<0.001

 

BMI ≤ 25

0.60 (0.46 to 1.53)

 
 

25 < BMI < 30

0.41 (0.33 to 0.66)

 
 

BMI ≥ 30

0.37 (0.23 to 0.40)

 

Alcohol dependence

  

0.037

 

Yes

0.64 (0.40 to 1.62)

 
 

No

0.43 (0.34 to 0.72)

 

Albumin

  

0.061

 

3 or 4

0.48 (0.37 to 1.50)

 
 

5

0.44 (0.30 to 0.62)

 

TNF-α

 

0.394a

<0.001

Current CD4 Count

 

−0.044b

0.067

  1. aSpearman correlation coefficient between TNF-α and CSF IGFBP1; bSpearman correlation coefficient between current CD4 count and CSF IGFBP1. IQR, interquartile range.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094